Researchers found that colibactin-induced mutational signatures were enriched in early-onset colorectal cancer cases.

Children with ALL who were overweight or obese at 2 or more time points had an increased risk of relapse and death.

Responses to an interview study demonstrated that patient education on palliative care led to better understanding of its benefits and greater utilization of these services.

In an average-risk colorectal cancer screening population, a blood-based circulating tumor DNA test is feasible.

This is not the first trial to show a lack of benefit when adding immunotherapy to SBRT in patients with early-stage, inoperable NSCLC.

Adjuvant cemiplimab could be a new standard of care for patients with cutaneous squamous cell carcinoma at high risk of recurrence, according to Danny Rischin, MD.